135 related articles for article (PubMed ID: 16950221)
1. The effects of guanfacine on context processing abnormalities in schizotypal personality disorder.
McClure MM; Barch DM; Romero MJ; Minzenberg MJ; Triebwasser J; Harvey PD; Siever LJ
Biol Psychiatry; 2007 May; 61(10):1157-60. PubMed ID: 16950221
[TBL] [Abstract][Full Text] [Related]
2. Context-processing deficits in schizotypal personality disorder.
Barch DM; Mitropoulou V; Harvey PD; New AS; Silverman JM; Siever LJ
J Abnorm Psychol; 2004 Nov; 113(4):556-68. PubMed ID: 15535788
[TBL] [Abstract][Full Text] [Related]
3. Guanfacine treatment of cognitive impairment in schizophrenia.
Friedman JI; Adler DN; Temporini HD; Kemether E; Harvey PD; White L; Parrella M; Davis KL
Neuropsychopharmacology; 2001 Sep; 25(3):402-9. PubMed ID: 11522468
[TBL] [Abstract][Full Text] [Related]
4. Dual-task information processing in schizotypal personality disorder: evidence of impaired processing capacity.
Harvey PD; Reichenberg A; Romero M; Granholm E; Siever LJ
Neuropsychology; 2006 Jul; 20(4):453-60. PubMed ID: 16846263
[TBL] [Abstract][Full Text] [Related]
5. Visual-spatial learning and memory in schizotypal personality disorder: continued evidence for the importance of working memory in the schizophrenia spectrum.
McClure MM; Romero MJ; Bowie CR; Reichenberg A; Harvey PD; Siever LJ
Arch Clin Neuropsychol; 2007 Jan; 22(1):109-16. PubMed ID: 17161580
[TBL] [Abstract][Full Text] [Related]
6. Guanfacine Augmentation of a Combined Intervention of Computerized Cognitive Remediation Therapy and Social Skills Training for Schizotypal Personality Disorder.
McClure MM; Graff F; Triebwasser J; Perez-Rodriguez M; Rosell DR; Koenigsberg H; Hazlett EA; Siever LJ; Harvey PD; New AS
Am J Psychiatry; 2019 Apr; 176(4):307-314. PubMed ID: 30654644
[TBL] [Abstract][Full Text] [Related]
7. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment.
Neylan TC; Lenoci M; Samuelson KW; Metzler TJ; Henn-Haase C; Hierholzer RW; Lindley SE; Otte C; Schoenfeld FB; Yesavage JA; Marmar CR
Am J Psychiatry; 2006 Dec; 163(12):2186-8. PubMed ID: 17151174
[TBL] [Abstract][Full Text] [Related]
8. Reduced processing resource availability in schizotypal personality disorder: evidence from a dual-task CPT study.
Moriarty PJ; Harvey PD; Mitropoulou V; Granholm E; Silverman JM; Siever LJ
J Clin Exp Neuropsychol; 2003 May; 25(3):335-47. PubMed ID: 12916647
[TBL] [Abstract][Full Text] [Related]
9. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study.
Mathai DS; Holst M; Rodgman C; Haile CN; Keller J; Hussain MZ; Kosten TR; Newton TF; Verrico CD
J Neuropsychiatry Clin Neurosci; 2018; 30(1):66-76. PubMed ID: 28641496
[TBL] [Abstract][Full Text] [Related]
10. Guanfacine potentiates the activation of prefrontal cortex evoked by warning signals.
Clerkin SM; Schulz KP; Halperin JM; Newcorn JH; Ivanov I; Tang CY; Fan J
Biol Psychiatry; 2009 Aug; 66(4):307-12. PubMed ID: 19520360
[TBL] [Abstract][Full Text] [Related]
11. Treatment of age-associated memory impairment with guanfacine.
McEntee WJ; Crook TH; Jenkyn LR; Petrie W; Larrabee GJ; Coffey DJ
Psychopharmacol Bull; 1991; 27(1):41-6. PubMed ID: 1862205
[TBL] [Abstract][Full Text] [Related]
12. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
13. The relationship between interview-based schizotypal personality dimension scores and the continuous performance test.
Bedwell JS; Kamath V; Compton MT
Schizophr Res; 2009 Mar; 108(1-3):158-62. PubMed ID: 19101122
[TBL] [Abstract][Full Text] [Related]
14. Guanfacine in children with autism and/or intellectual disabilities.
Handen BL; Sahl R; Hardan AY
J Dev Behav Pediatr; 2008 Aug; 29(4):303-8. PubMed ID: 18552703
[TBL] [Abstract][Full Text] [Related]
15. Context processing in schizotypal personality disorder: evidence of specificity of impairment to the schizophrenia spectrum.
McClure MM; Barch DM; Flory JD; Harvey PD; Siever LJ
J Abnorm Psychol; 2008 May; 117(2):342-54. PubMed ID: 18489210
[TBL] [Abstract][Full Text] [Related]
16. The effects of guanfacine on working memory performance in patients with localization-related epilepsy and healthy controls.
Swartz BE; McDonald CR; Patel A; Torgersen D
Clin Neuropharmacol; 2008; 31(5):251-60. PubMed ID: 18836342
[TBL] [Abstract][Full Text] [Related]
17. Integrating working memory capacity and context-processing views of cognitive control.
Redick TS; Engle RW
Q J Exp Psychol (Hove); 2011 Jun; 64(6):1048-55. PubMed ID: 21644190
[TBL] [Abstract][Full Text] [Related]
18. Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial.
Doraiswamy PM; Babyak MA; Hennig T; Trivedi R; White WD; Mathew JP; Newman MF; Blumenthal JA
Psychopharmacol Bull; 2007; 40(2):54-62. PubMed ID: 17514186
[TBL] [Abstract][Full Text] [Related]
19. Impaired context maintenance in mild to moderately depressed students.
Msetfi RM; Murphy RA; Kornbrot DE; Simpson J
Q J Exp Psychol (Hove); 2009 Apr; 62(4):653-62. PubMed ID: 19048449
[TBL] [Abstract][Full Text] [Related]
20. Effects of the D1 dopamine receptor agonist dihydrexidine (DAR-0100A) on working memory in schizotypal personality disorder.
Rosell DR; Zaluda LC; McClure MM; Perez-Rodriguez MM; Strike KS; Barch DM; Harvey PD; Girgis RR; Hazlett EA; Mailman RB; Abi-Dargham A; Lieberman JA; Siever LJ
Neuropsychopharmacology; 2015 Jan; 40(2):446-53. PubMed ID: 25074637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
